久久久精品欧美一区二区三区,国产欧美久久久精品影院,亚洲AV福利天堂一区二区三亚洲欧洲日韩国产AⅤ在线,亚洲成av人在线视,四虎国产精品永久地址99自拍三区一级国产片,亚洲男人的天堂久久无在线观看免费黄视频,亚洲一级特黄大片在线播放,国产成人精品区在线观看

Vaccine
Home > Application > Vaccine > Virus-like particle (VLP) vaccine

Virus-like particle (VLP) vaccine

Most currently available vaccines are mainly based on inactivated or attenuated live vaccines. Although these traditional vaccines have been used effectively against various infectious diseases, some of them have several limitations, including low likelihood of inducing a stronger immune response and their poor efficacy. Recent outbreaks of infectious diseases demonstrate the need to develop robust vaccines to overcome these limitations. The main challenge is to develop new technical approaches and boost immunity without compromising safety, efficacy and tolerability. Recent advances in vaccines based on DNA, mRNA, and recombinant viral vectors provide effective vaccine development methods for difficult-to-target pathogens and control infectious disease outbreaks.


Virus-like particle (VLP) technology provides an alternative platform for the development of effective vaccines against serious infectious diseases, and it is being developed in parallel with vaccines based on mRNA and viral vectors. VLPs are also much more immunogenic than other subunit vaccines because they present repetitive epitopes on their surface, making them more reliably detectable by the immune system. On the other hand, subunit vaccines may be less immunogenic due to misfolding of the target antigen or insufficient presentation to the immune system, and moreover, they require adjuvants and repeated vaccinations to elicit an adequate immune response. The term virus-like particle was first described by Fraenkel-Conrat and Williams (1955) by recombining tobacco mosaic virus (TMV) particles from purified RNA and protein components. The potential of these nanostructures to induce potent immune responses was then further investigated. The VLP platform can overcome various problems typically associated with traditional vaccines; specifically, infectivity, reversion to virulent forms, mutation risk associated with live attenuated vaccines, and reduced immunogenicity, toxicity instability, low yield and long formulation time associated with inactivated vaccines.


These bio-inspired nanostructures feature repetitive and high-density antigens from different viruses, helping to trigger a strong immune response. Furthermore, these highly immunogenic molecules possess the self-assembling properties of viral proteins. They are biocompatible and have the potential for structural flexibility during synthesis. They can be chemically or genetically modified and exhibit increased stability, uniformity, and functionality, and are considered effective tools in various biomedical applications. Depending on the presence or absence of a lipid membrane, VLPs can be classified as either enveloped or nonenveloped.


However, some of the key challenges associated with VLPs are low stability, difficult downstream processes, high production costs, and sensitivity to environmental conditions. Many different VLPs have been synthesized in various expression systems, such as bacteria, yeast, mammalian cells, insect cells, and plants. VLP-based vaccines have the potential to be used to treat various infectious diseases, including HIV, influenza, hepatitis B, hepatitis E, malaria, Ebola virus, SARS-CoV-2, Zika virus, dengue fever, and foot-and-mouth disease, among others. Several VLP-based vaccines have been licensed and marketed, including Engerix-B? and Recombivax HB? for HBV, Gardasil? and Cervarix? for HPV, Hecolin? for HEV, and Mosquirix? for malaria.

Related Products
Contact Us
  • Tel.: +86 021 6434 0155
  • E-Mail: marketing@duoningbio.com
  • Address: Building 30, No. 1525 Minqiang Road, Songjiang District, Shanghai
Message

Copyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: Reanod

WeChat
WeChat

Message-

Duoning Biotechnology

+86 021 6434 0155

成人免费无码精品国产电影| 欧美亚洲国产日韩欧美4p| 久久久久人妻精品一区三寸蜜桃| 国产成人精品高清在线观看99| 亚洲精品无码高潮喷水在线| 亚洲午夜精品无码专区在线播放| 乱码卡一卡二新区网站| 国产亚洲精品福利在线无卡一| HD最新国产人妖TS视频| 亚洲中文一本无码av在线无码| 亚洲欧美另类精品在线观看| 国产成人亚洲精品影院| 亚洲AV秘无码一区二区三资讯,| 亚洲国产七七久久桃花| 国产在线综合一区二区三区| 日韩v在线亚洲视频在线看| 日本高清不卡视频| 特级丰满少妇一级AAAA爱毛片| 久久99国产热这里只有精品| 久久99久久国产精品国产99视频精品免视看9| 国产精品亚洲第一区在线观看| 亚洲乱码一区二区三区在线欧美| 天天搞夜夜爽aaaaa级毛片免费视频| 国产在线综合一区二区三区| 午夜性爽视频男人的天堂| 人妻无码αv中文字幕久久| 人妻系列AV无码专区| 99久久人妻无码精品系列| 久久精品国产69国产精品亚洲| 国产欧美成人精品久久久久| 日韩一区无码高清| JAPANESEHD熟女熟妇伦,啊轻点灬大JI巴太粗太长了| 最新国产成人精品区在线观看| 婷婷色婷婷开心五月四房播播| AV永久免费网站在线观看| 亚洲AV日韩AV永久无码色欲| 2021AAVV年本站提供91久久精品| 大香伊人久久精品一区二区| 少妇激情无码av一区二区| 亚洲精品国产成人片| 超碰97人人模人人爽人人|